Navigation Links
Code Hennessy & Simmons LLC Announces Sale of Suture Express, Inc.
Date:1/28/2010

CHICAGO, Jan. 28 /PRNewswire/ -- Code Hennessy & Simmons LLC ("CHS") announced the sale of Suture Express, Inc., a portfolio investment of CHS Private Equity V LP and Linden LLC, to Diamond Castle Partners, a New York-based private equity firm.  

Suture Express is a distributor of sutures, endo-mechanical products and other disposable medical and surgical products.  Suture Express offers over 1,600 acute care hospitals and surgery centers a comprehensive assortment of over 6,000 SKUs with no minimum order size, no required order frequency and guaranteed next-day delivery for most orders.  For additional information, visit www.sutureexpress.com.

CHS led the investment in Suture Express in August 2006 and partnered with Linden in a buyout from the company's founders.  CHS and Linden successfully transitioned the leadership of the business and have worked closely with management to significantly grow revenue and market share as well as expand the company's customer base and product offering.

Ed Kuklenski, President and CEO of Suture Express, said, "CHS and Linden were instrumental in helping us build a world-class board of directors and achieve numerous growth initiatives.  Their combined healthcare expertise was invaluable as we grew our business substantially over the past several years.  We now look forward to working with Diamond Castle Partners to continue to build upon our past success."

Tom Formolo, Partner at CHS, said, "It was a pleasure to work with Ed Kuklenski and the management team at Suture Express.  With the company's history of growth, unique business model and best-in-class customer service levels, we are confident Suture Express will continue its track record of success and remarkable customer loyalty."   Ed Lhee, Partner at CHS, stated, "Suture Express fit well with our healthcare services strategy to pursue businesses that help improve the quality and efficiency of healthcare while providing value-added services for customers."  

CHS is a Chicago-based private equity firm specializing in private equity investments and recapitalizations of middle market companies in partnership with management. CHS targets well-managed companies focused on growth with enterprise values between $75 million and $1.0 billion. With particular expertise in the Business & Consumer Services, Consumer, Distribution, and Infrastructure & Industrial Products sectors, CHS has completed 73 platform investments and 211 add-on investments. Founded in 1988, CHS has formed five private equity funds and currently manages over $2.8 billion of capital. For additional information about CHS, visit www.chsonline.com.

Linden is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life science industries.  Linden's strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations.  Linden's portfolio includes BarrierSafe Solutions International, Behavioral Centers of America, Corpak MedSystems, Drayer Physical Therapy Institute, Focused Health Solutions and Ranir.  For additional information about Linden, please refer to the firm's website at www.lindenllc.com.

William Blair & Company, L.L.C. provided financial advisory services to Suture Express on the transaction and Kirkland & Ellis LLP provided legal advice.  

SOURCE Code Hennessy & Simmons LLC

RELATED LINKS
http://www.chsonline.com

'/>"/>

SOURCE Code Hennessy & Simmons LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Get Your Fruits & Veggies: CDC
2. Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer
3. Story ideas from molecular & cellular proteomics
4. Job picture for 2006 chemistry grads reasonably good, C&EN reports
5. Debut issue of Foot & Ankle Specialist
6. Congressional R&D Caucus co-chairs join scientists, engineers and graduate students
7. IU Health & Wellness: Research and insights from Indiana University
8. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
9. European Society of Human Reproduction & Embryology 24th annual meeting
10. IU Health & Wellness: New research findings from the Kinsey Institute
11. Riley Hospital for Children & Capital Institute of Pediatrics become international sister hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... An April 24th article on Yahoo! Beauty discusses ... with the help of a weight loss surgery. The woman, declaring “I will not hate ... been left following her dramatic weight loss. Dr. Feiz & Associates notes that, while it ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage ... unmet medical needs, today announced that it will ... development program, based on its proprietary self-delivering RNAi ... (SID) 76 th Annual Meeting.  The SID ... relevant to skin health and disease through education, ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: